A. Isiklar Et Al. , "Alpelisib induced interstitial lung disease in a patient with advanced breast cancer," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.2, pp.484-488, 2023
Isiklar, A. Et Al. 2023. Alpelisib induced interstitial lung disease in a patient with advanced breast cancer. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.2 , 484-488.
Isiklar, A., Basaran, G., Sepin, B., Gumusay, Ö., Kocagoz, A. S., & Cuhadaroglu, Ç., (2023). Alpelisib induced interstitial lung disease in a patient with advanced breast cancer. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.2, 484-488.
Isiklar, Aysun Et Al. "Alpelisib induced interstitial lung disease in a patient with advanced breast cancer," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.2, 484-488, 2023
Isiklar, Aysun Et Al. "Alpelisib induced interstitial lung disease in a patient with advanced breast cancer." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.2, pp.484-488, 2023
Isiklar, A. Et Al. (2023) . "Alpelisib induced interstitial lung disease in a patient with advanced breast cancer." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.2, pp.484-488.
@article{article, author={Aysun Isiklar Et Al. }, title={Alpelisib induced interstitial lung disease in a patient with advanced breast cancer}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2023, pages={484-488} }